Search

31 January 2025 - This document is the technical supplement to the Australian Respiratory Surveillance Report (ARSR) series. It describes the technical background and considerations to help interpret the ARSR surveillance data reported nationally for COVID-19, influenza and respiratory syncytial virus.

19 March 2021 - This statement from the Australian Technical Advisory Group on Immunisation (ATAGI) updates advice previous provided on 16 March. It follows the European Medicines Agency (EMA) safety review of the AstraZeneca COVID-19 vaccine.

16 April 2020 - A statement from the Australian Health Protection Principal Committee (AHPPC) about the next phase of modelling to better understand the present state of the coronavirus epidemic.

19 June 2025 - The 2022 Australian Influenza Surveillance Report (AISR) provides a national influenza season summary. It includes information about influenza activity, severity, impact, at-risk populations, virology, and vaccine effectiveness.

30 June 2025 - People with specific medical risk conditions may require extra vaccines.

26 June 2025 - If you provide residential aged care services, you have certain responsibilities. You must provide quality care and services, manage fees and charges, and meet Australian Government requirements.

24 February 2020 - Statement from Australian Health Protection Principal Committee on the Community Response to novel coronavirus.

15 December 2022 - Learn about our latest news RSS feed – what it is, how it works and how to use it to read our latest news.

2 September 2021 - Australian Health Protection Principal Committee (AHPPC) statement on managed quarantine for international arrivals including hotel quarantine

13 December 2021 - Spikevax (Moderna), also referred to as the Moderna COVID-19 vaccine, has been provisionally approved for use as a COVID-19 booster vaccine in people aged 18 years and older by the Therapeutic Goods Administration (TGA).